High throughput sequencing (HTS) is a powerful molecular tool for analyzing the genomic data of gynecological samples. HTS enables researchers to identify genetic alterations associated with gynecological diseases, as well as to detect the presence of infectious agents in gynecological samples. HTS can also be used to study the transcriptome and epigenetic profile of gynecological samples, providing valuable insights into the mechanisms underlying gynecological diseases. HTS has been widely used in the study of gynecological cancers, such as ovarian, cervical, and endometrial cancer. Using HTS, researchers can identify the genetic alterations associated with these types of cancer and develop targeted therapies to treat them. HTS is also useful for identifying novel biomarkers to diagnose and monitor gynecological cancers. In addition to its use in cancer research, HTS can also be used to study non-malignant gynecological diseases such as endometriosis and polycystic ovary syndrome. HTS can help identify genetic variants associated with these diseases and provide insights into their underlying mechanisms. Furthermore, HTS can be used to detect the presence of infectious agents such as HPV, which can cause cervical cancer. Overall, HTS is a powerful tool for studying gynecological diseases. HTS has enabled researchers to gain valuable insights into the causes and development of these diseases, as well as to develop targeted therapies for treating them. As HTS technologies continue to advance, it is likely that HTS will become an increasingly important tool for gynecological research.
Title : Evaluate the changes in SP-D levels in plasma during different phases of the menstrual cycle recruited from the Well- Adult Surfactant Protein Study (WASP)
Natnicha Kitti udom, University College London, Thailand
Title : Synergistic antifibrotic potential of protocatechuic acid and D-Carvone in liver protection
Ling Yin, Hefei Comprehensive National Science Center, China
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin-Khameh, Baylor College of Medicine, United States
Title : Non-ablative radiofrequency for pelvic floor dysfunction and female intimate anti-aging: a 6-month prospective multi-centre cohort objectiv
Shaadaiti Wufuer, First Affiliated Hospital of Xinjiang Medical University, China
Title : Benign gynecological conditions and lifetime contraceptive patterns: a population-based analysis of the 2022–2023 national survey of family growth
Mayi Gnofam, Stony Brook University, United States
Title : Hysteroscopic endometrial resection with resectoscope versus Novasure ablation: A look at patient satisfaction with treatment of abnormal uterine bleeding and rates of progression to hysterectomy
Genevieve Kan, West Gippsland Healthcare Group, Australia